Navigation Links
Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group

WALTHAM, Mass., Oct. 29 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the global spinal nonfusion technology market will increase from approximately $400 million in 2008 to almost $2 billion by 2013. MRG's new Global Markets for Spinal Nonfusion Technologies 2009 report finds this market will be fueled by increased product approvals across the US, Europe, and Asia Pacific. Further adding to market growth will be the increase in average selling prices prompted by sales of these premium-priced nonfusion devices.

With the highest average selling prices of all three regions, the US contributed the majority of revenues to the global spinal nonfusion technology market in 2008, despite being a young market compared to Europe. The spinal nonfusion technology market is more developed in Europe, with a larger number of firms competing on price. Also, many of the devices lack full reimbursement in Europe, which contributes to lower pricing because many patients are unwilling to pay the full price of the nonfusion technology. Although the number of spinal nonfusion procedures performed in Europe was 80% of the volume observed in the US in 2008, price differences resulted in a total European market value of less than half of that in the US market.

New products, such as the M6-L lumbar artificial disc from Spinal Kinetics and the Barricaid annulus repair device from Intrinsic Therapeutics, will be released across the three regions and will lead to an intensification of marketing and training efforts on the part of manufacturers to promote the efficacy of spinal nonfusion treatments.

"As more surgeons become familiar with long-term clinical data and receive training on the techniques, an increasing number will adopt spinal nonfusion treatments in their practice and concerns regarding long-term efficacy will recede," says Deanna Vankessel, Analyst at MRG. "The release of new spinal nonfusion products will result in an influx of favorable clinical data and increased marketing of these new devices and technologies, fueling physician awareness and adoption."

MRG's Global Markets for Spinal Nonfusion Technologies 2009 report evaluates the performance of the spinal nonfusion technology market from 2007 to 2013 in the US, Europe and Asia Pacific. Each chapter includes an examination of artificial disc, dynamic stabilization, annulus repair, nuclear disc prosthesis, and facet arthroplasty procedures, as well as average selling prices and sales segmented by procedure. Chapters also contain a detailed account of the drivers and limiters that will impact the market and analysis of the leading competitors.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through syndicated reports, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101

    Elizabeth Marshall
    Decision Resources Inc.

SOURCE Millennium Research Group

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
(Date:11/24/2015)... N.Y. , Nov. 24, 2015 Avery ... System, is pleased to announce the appointment of ... Dr. ... pediatric cardiology at Children,s Hospital, Uppsala University, Uppsala and ... From 1984-1986, he was a fellow at the Cardiovascular ...
(Date:11/24/2015)... , November 24, 2015 ... --> adds Latest Guidebook for ... of 217 pages published in November 2015 to ... online business intelligence library at . ... of the fastest growing global economies with a ...
(Date:11/24/2015)... , Nov. 24, 2015  Ascendant Solutions, Inc. (Pink Sheets: ... its Board of Directors has declared a special 1 percent ... dividend is payable December 14, 2015, to shareholders of record ... form of additional shares of common stock. ... Board is a strong endorsement of our confidence in Ascendant,s ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
(Date:11/24/2015)... ... November 24, 2015 , ... The ... comes to several aspects of orthopedic care. They have received recognition for excellence ... general orthopedic care. , Becker's Hospital Review selected hospitals for inclusion based ...
(Date:11/24/2015)... ... 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus Medical ... the United States grew 400 percent between 1999 and 2010, far more than the ... percent of all fatal drug overdoses. (1) , While oxycodone and the extended release ...
Breaking Medicine News(10 mins):